Condensed Balance Sheets - USD ($)	Mar. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 206,948	$ 759,742
Prepaid expenses and other current assets	51,296	77,296
Total current assets	258,244	837,038
Equipment and furnishings, net	354	999
Other assets	1,475	1,475
Total assets	260,073	839,512
Current liabilities:
Accounts payable	1,101,488	1,056,662
Accrued expenses and other current liabilities	1,293,377	1,202,279
Total current liabilities	2,394,865	2,258,941
Commitments and contingencies
Stockholders’ equity (deficit):
Preferred Stock, $0.01 par value, 833,333 shares authorized, including 50,000 shares of Series B Junior Participating Preferred Stock; no shares issued and outstanding
Common stock, $0.001 par value, 62,393,940 shares authorized; 495,092 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively	495	495
Additional paid-in capital	488,679,720	488,675,792
Accumulated deficit	(490,815,007)	(490,095,716)
Total stockholders’ equity (deficit)	(2,134,792)	(1,419,429)
Total liabilities and stockholders’ equity (deficit)	$ 260,073	$ 839,512